BACKGROUND: The peptide hormone gastrin is a recognised growth factor for gastrointestinal (GI) tumour cells. Carboxyamidated gastrins bind to the cell surface gastrin/cholecystokinin B (CCK-B) receptor which can be expressed as either a normal or a truncated isoform (delta CCK-B). AIMS: To compare gastrin gene expression with delta CCK-B and total CCK-B (both isoforms) gene expression in both GI and non-GI tract derived human tumour cell lines. METHODS: Total RNA was extracted and gene expression was assayed by the reverse transcription-polymerase chain reaction followed by Southern blotting and hybridisation with specific oligo probes. RESULTS: Gastrin was expressed by 5/5 gastric and 7/8 colorectal cell lines. Coexpression of gastrin CCK-B isoform was found in 80% of gastric and 75% of colorectal cell lines. Non-GI cell lines, with the exception of a lymphoblastic leukaemia cell line, showed no coexpression. The truncated receptor, delta CCK-B, was shown in 3/5 gastric and 5/8 colorectal cell lines and was always coexpressed with gastrin. CONCLUSIONS: The truncated gastrin receptor, delta CCK-B, is coexpressed with gastrin in 8/13 GI tumour cell lines. Gastrin and CCK-B receptor isoforms may be involved in maintaining autocrine/paracrine growth pathways in GI cancer cells.
BACKGROUND: The peptide hormone gastrin is a recognised growth factor for gastrointestinal (GI) tumour cells. Carboxyamidated gastrins bind to the cell surface gastrin/cholecystokinin B (CCK-B) receptor which can be expressed as either a normal or a truncated isoform (delta CCK-B). AIMS: To compare gastrin gene expression with delta CCK-B and total CCK-B (both isoforms) gene expression in both GI and non-GI tract derived humantumour cell lines. METHODS: Total RNA was extracted and gene expression was assayed by the reverse transcription-polymerase chain reaction followed by Southern blotting and hybridisation with specific oligo probes. RESULTS:Gastrin was expressed by 5/5 gastric and 7/8 colorectal cell lines. Coexpression of gastrinCCK-B isoform was found in 80% of gastric and 75% of colorectal cell lines. Non-GI cell lines, with the exception of a lymphoblastic leukaemia cell line, showed no coexpression. The truncated receptor, delta CCK-B, was shown in 3/5 gastric and 5/8 colorectal cell lines and was always coexpressed with gastrin. CONCLUSIONS: The truncated gastrin receptor, delta CCK-B, is coexpressed with gastrin in 8/13 GI tumour cell lines. Gastrin and CCK-B receptor isoforms may be involved in maintaining autocrine/paracrine growth pathways in GI cancer cells.
Authors: G S Baldwin; A Casey; T Mantamadiotis; K McBride; A M Sizeland; C M Thumwood Journal: Biochem Biophys Res Commun Date: 1990-07-31 Impact factor: 3.575
Authors: K Yoshida; J Bolodeoku; T Sugino; S Goodison; Y Matsumura; B F Warren; T Toge; E Tahara; D Tarin Journal: Cancer Res Date: 1995-10-01 Impact factor: 12.701
Authors: Y Matsushima; Y Kinoshita; H Nakata; Y Inomoto-Naribayashi; M Asahara; C Kawanami; A Nakamura; M Ito; T Matsui; T Fujiwara Journal: Jpn J Cancer Res Date: 1994-08
Authors: Beatriz Domingo; María Gasset; Mario Durán-Prado; Justo P Castaño; Antonio Serrano; Thierry Fischer; Juan Llopis Journal: Cell Mol Life Sci Date: 2010-05-08 Impact factor: 9.261
Authors: Jose Córdoba-Chacón; Manuel D Gahete; Mario Duran-Prado; Ana I Pozo-Salas; María M Malagón; F Gracia-Navarro; Rhonda D Kineman; Raul M Luque; Justo P Castaño Journal: Cell Mol Life Sci Date: 2010-04 Impact factor: 9.261